Healthletter stands at the intersection of purpose and innovation.
Our mission is to achieve transformative healthcare outcomes by combining physical healthcare infrastructure with cutting-edge digital and biotechnology technologies. As a diversified Saudi investment group in the healthcare and digital health sectors, we are shaping a new era of smart, sustainable, and inclusive healthcare in emerging and developed markets.
Why invest with us?
Join us in shaping the future of healthcare.
Financial Strength
Control income-generating assets with a diversified portfolio.
Diversified practice
Hospitals, digital health platforms, biotechnology projects, and academic institutions.
Strategic vision
AI-powered innovation and global expansion.
Our strategic pillars
Core Healthcare Operations: Maximizing Profitability in Hospitals and Clinics Across Saudi Arabia, Tunisia, and Bangladesh.
Discover our strategic roadmapDigital health and artificial intelligence
Expanding AI-powered platforms such as SoulHelper, PrecisionMedAI, and Fax.
Academic and training excellence
Developing the “Global Medical College” as a regional training center.
Innovation, Research and Development
Building a cross-border research ecosystem to incubate and commercialize intellectual property.
IPO and Capital Strategy
Moving towards a public offering or merger with a private purpose vehicle by 2027-2028.
Investment opportunities
Unprecedented Growth Potential: Healthliter offers a unique opportunity to invest in a globally integrated and diversified healthcare group. Our hybrid model combines stable revenues from core healthcare assets with high-growth biotechnology and digital ventures.
- Revenue growth: Expected at 32% per annum (2025-2029).
- Earnings expansion: Expected at 80% over five years.
- ROI: Expected between 28% and 36%, with a 3.0x-5.5x return to pre-IPO investors.
- Five-year financial forecast
- 2025: $150 million in revenue, 8% operating margin.
- 2029: Over $350 million in revenue, 22% operating margin.
Our investment portfolio
Diversified assets for sustainable growth
Explore our portfolio in detail01 Hospitals
Stable profit margins and regional expansion.
02 Digital health
SoulHelper (AI mental health), PrecisionMedAI (oncology software) – high-growth technologies.
03 Biotechnology
Fax (an AI-powered platform) and Origin Life Sciences – cutting-edge innovations.
04 Education
“Global Medical College” – Integrating excellence in healthcare and academics.
Investor Relations
Transparency and participation
We are committed to keeping our investors informed through:
01 Quarterly reports
Includes key performance indicators such as revenue, profit, and patient growth.
02 Scenario modeling
Clear IPO valuation expectations ($750M base, $1.2B upside).
03 Focus on ESG
Highlighting our impact in education, mental health access, and the use of AI in clinical trials.
Upcoming landmarks
2025
Preparing for the IPO and re-identifying the region.
2027
Submitting an IPO application and expanding digital services.
2029
Entering global markets and launching an investment studio.